{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:25:21Z","timestamp":1764084321750,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.spen.2021.100922","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T10:47:58Z","timestamp":1630752478000},"page":"100922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases"],"prefix":"10.1016","volume":"40","author":[{"given":"Brianna N","family":"Brun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn C","family":"Aylward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2021.100922_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01668270","article-title":"Uber Meningitis serosa and verwandte Zustande","volume":"9","author":"Quincke","year":"1897","journal-title":"Dtsch Z Nervenheilkd"},{"key":"10.1016\/j.spen.2021.100922_bib0002","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pediatrneurol.2013.05.019","article-title":"Pediatric idiopathic intracranial hypertension: A need for clarification","volume":"49","author":"Aylward","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0003","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pediatrneurol.2016.04.007","article-title":"Manifestations of pediatric intracranial hypertension from the intracranial hypertension registry","volume":"61","author":"Aylward","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pediatrneurol.2015.03.028","article-title":"Novel magnetic resonance imaging findings in children with intracranial hypertension","volume":"53","author":"Hirfanoglu","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/bjophthalmol-2015-307043","article-title":"Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension","volume":"100","author":"Gospe","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.spen.2021.100922_bib0006","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2021.100922_bib0007","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0161-6420(98)99039-X","article-title":"Magnetic resonance imaging in pseudotumor cerebri","volume":"105","author":"Brodsky","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2021.100922_bib0008","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3174\/ajnr.A2404","article-title":"Pseudotumor cerebri: Brief review of clinical syndrome and imaging findings","volume":"32","author":"Degnan","year":"2011","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.spen.2021.100922_bib0009","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.crad.2011.12.002","article-title":"Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension","volume":"67","author":"Maralani","year":"2012","journal-title":"Clin Radiol"},{"key":"10.1016\/j.spen.2021.100922_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01658107.2012.738759","article-title":"MRI findings of elevated intracranial pressure in cerebral venous thrombosis versus idiopathic intracranial hypertension with transverse sinus stenosis","volume":"37","author":"Ridha","year":"2013","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.spen.2021.100922_bib0011","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/WNO.0000000000000303","article-title":"Brain Imaging in Idiopathic Intracranial Hypertension","volume":"35","author":"Bidot","year":"2015","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.spen.2021.100922_bib0012","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejrad.2019.04.023","article-title":"Systematic review and meta-analysis of MRI signs for diagnosis of idiopathic intracranial hypertension","volume":"116","author":"Kwee","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.spen.2021.100922_bib0013","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1067\/j.cpradiol.2019.02.012","article-title":"Idiopathic intracranial hypertension: Review of clinical syndrome, imaging findings, and treatment","volume":"49","author":"Rehder","year":"2020","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.spen.2021.100922_bib0014","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/WCO.0000000000000885","article-title":"MRI findings as markers of idiopathic intracranial hypertension","volume":"34","author":"Barkatullah","year":"2021","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0883073816671855","article-title":"Imaging features of idiopathic intracranial hypertension in children","volume":"32","author":"Hartmann","year":"2017","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0016","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/0883073809338874","article-title":"Magnetic resonance imaging changes in idiopathic intracranial hypertension in children","volume":"25","author":"Lim","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0017","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00381-014-2579-0","article-title":"MR imaging findings in children with pseudotumor cerebri and comparison with healthy controls","volume":"31","author":"Gorkem","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.spen.2021.100922_bib0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2019.04.010","article-title":"Magnetic resonance imaging findings in pediatric pseudotumor cerebri syndrome","volume":"99","author":"Kohli","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0019","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaapos.2017.08.003","article-title":"Diagnostic criteria in pediatric intracranial hypertension","volume":"21","author":"Inger","year":"2017","journal-title":"J AAPOS"},{"key":"10.1016\/j.spen.2021.100922_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNO.0000000000000114","article-title":"The idiopathic intracranial hypertension treatment trial: design considerations and methods","volume":"34","author":"Friedman","year":"2014","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.spen.2021.100922_bib0021","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"Wall","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.spen.2021.100922_bib0022","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WNO.0000000000000322","article-title":"Safety and tolerability of acetazolamide in the idiopathic intracranial hypertension treatment trial","volume":"36","author":"ten Hove","year":"2016","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.spen.2021.100922_bib0023","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/head.13144","article-title":"The idiopathic intracranial hypertension treatment trial: a review of the outcomes","volume":"57","author":"Smith","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.spen.2021.100922_bib0024","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","article-title":"The idiopathic intracranial hypertension treatment trial: clinical profile at baseline","volume":"71","author":"Wall","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0025","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/head.13153","article-title":"Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial","volume":"57","author":"Friedman","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.spen.2021.100922_bib0026","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1167\/iovs.14-14960","article-title":"Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability","volume":"55","author":"Auinger","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.spen.2021.100922_bib0027","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1167\/iovs.14-14961","article-title":"Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features","volume":"55","author":"Auinger","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.spen.2021.100922_bib0028","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00415-015-7838-9","article-title":"CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"262","author":"Kattah","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0029","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/bjophthalmol-2016-309852","article-title":"Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial","volume":"101","author":"Wall","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.spen.2021.100922_bib0030","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ophtha.2015.06.003","article-title":"Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial","volume":"122","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.spen.2021.100922_bib0031","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1167\/iovs.14-14243","article-title":"Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)","volume":"55","author":"Keltner","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.spen.2021.100922_bib0032","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1212\/WNL.0000000000001687","article-title":"Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results","volume":"84","author":"Digre","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2021.100922_bib0033","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1212\/WNL.0000000000003280","article-title":"Quality of life at 6 months in the idiopathic intracranial hypertension treatment trial","volume":"87","author":"Bruce","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2021.100922_bib0034","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/WNO.0000000000000327","article-title":"Factors affecting visual field outcomes in the idiopathic intracranial hypertension treatment trial","volume":"36","author":"Cello","year":"2016","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.spen.2021.100922_bib0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1212\/WNL.0000000000001896","article-title":"Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension","volume":"85","author":"Wall","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2021.100922_bib0036","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajo.2017.01.004","article-title":"The longitudinal idiopathic intracranial hypertension trial: outcomes from months 6-12","volume":"176","author":"Wall","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.spen.2021.100922_bib0037","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/WNO.0000000000000648","article-title":"Genetic survey of adult-onset idiopathic intracranial hypertension","volume":"39","author":"Kuehn","year":"2019","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.spen.2021.100922_bib0038","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pediatrneurol.2020.11.008","article-title":"Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children, Associated With COVID-19","volume":"115","author":"Baccarella","year":"2021","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100922_bib0039","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0140-6736(20)31725-6","article-title":"Pseudotumor cerebri syndrome associated with MIS-C: a case report","volume":"396","author":"Verkuil","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2021.100922_bib0040","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0325-2020","article-title":"COVID-19 and benign intracranial hypertension: A case report","volume":"53","author":"Noro","year":"2020","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.spen.2021.100922_bib0041","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/0333102420965963","article-title":"Isolated intracranial hypertension associated with COVID-19","volume":"40","author":"Silva","year":"2020","journal-title":"Cephalalgia"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909121000504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909121000504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:38:12Z","timestamp":1761028692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909121000504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":41,"alternative-id":["S1071909121000504"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2021.100922","relation":{},"ISSN":["1071-9091"],"issn-type":[{"type":"print","value":"1071-9091"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2021.100922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100922"}}